Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 5 | 2018 | 578 | 0.700 |
Why?
|
| Glioma | 3 | 2018 | 131 | 0.650 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2017 | 339 | 0.410 |
Why?
|
| Mixed Tumor, Mesodermal | 1 | 2010 | 2 | 0.390 |
Why?
|
| Skin Neoplasms | 2 | 2004 | 231 | 0.390 |
Why?
|
| Neuroectodermal Tumors | 1 | 2010 | 2 | 0.390 |
Why?
|
| Microvessels | 1 | 2009 | 27 | 0.370 |
Why?
|
| Temporal Lobe | 1 | 2009 | 42 | 0.370 |
Why?
|
| Ovarian Neoplasms | 1 | 2010 | 90 | 0.360 |
Why?
|
| Astrocytoma | 2 | 2010 | 29 | 0.350 |
Why?
|
| Immunohistochemistry | 6 | 2010 | 613 | 0.350 |
Why?
|
| Genes, erbB-1 | 1 | 2008 | 16 | 0.340 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2008 | 22 | 0.330 |
Why?
|
| Chromosome Aberrations | 1 | 2008 | 30 | 0.330 |
Why?
|
| Hippocampus | 1 | 2009 | 187 | 0.330 |
Why?
|
| Brain | 2 | 2005 | 949 | 0.320 |
Why?
|
| Brain Chemistry | 1 | 2005 | 31 | 0.270 |
Why?
|
| Neurons | 2 | 2009 | 395 | 0.270 |
Why?
|
| Meningeal Neoplasms | 2 | 2017 | 42 | 0.270 |
Why?
|
| Meningioma | 2 | 2017 | 48 | 0.260 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2018 | 143 | 0.260 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2004 | 7 | 0.260 |
Why?
|
| Lectins | 1 | 2004 | 10 | 0.260 |
Why?
|
| Cell Communication | 1 | 2004 | 28 | 0.260 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2004 | 10 | 0.250 |
Why?
|
| Cell Adhesion Molecules | 1 | 2004 | 47 | 0.250 |
Why?
|
| Humans | 25 | 2018 | 29168 | 0.250 |
Why?
|
| Microglia | 1 | 2004 | 47 | 0.250 |
Why?
|
| Middle Aged | 13 | 2018 | 11167 | 0.250 |
Why?
|
| Antigens, CD | 1 | 2004 | 120 | 0.240 |
Why?
|
| Cytokines | 1 | 2004 | 243 | 0.230 |
Why?
|
| Hyperplasia | 1 | 2002 | 42 | 0.230 |
Why?
|
| Dementia | 1 | 2005 | 225 | 0.230 |
Why?
|
| Glioblastoma | 2 | 2018 | 144 | 0.220 |
Why?
|
| Alzheimer Disease | 1 | 2005 | 300 | 0.220 |
Why?
|
| Female | 16 | 2018 | 18308 | 0.210 |
Why?
|
| Melanoma | 1 | 2002 | 150 | 0.200 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2013 | 61 | 0.200 |
Why?
|
| Aged | 10 | 2018 | 9602 | 0.190 |
Why?
|
| Vasculitis, Central Nervous System | 1 | 2018 | 5 | 0.170 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 40 | 0.170 |
Why?
|
| Genomics | 1 | 2018 | 87 | 0.160 |
Why?
|
| Tumor Burden | 1 | 2017 | 64 | 0.160 |
Why?
|
| Eye Evisceration | 1 | 2017 | 1 | 0.160 |
Why?
|
| Acrylic Resins | 1 | 2017 | 2 | 0.160 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2017 | 69 | 0.160 |
Why?
|
| Orbital Implants | 1 | 2017 | 2 | 0.160 |
Why?
|
| Survival Rate | 3 | 2018 | 824 | 0.160 |
Why?
|
| Prosthesis Implantation | 1 | 2017 | 34 | 0.160 |
Why?
|
| Orbit | 1 | 2017 | 18 | 0.160 |
Why?
|
| Adult | 8 | 2017 | 8580 | 0.150 |
Why?
|
| Genome, Human | 1 | 2017 | 149 | 0.150 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 158 | 0.150 |
Why?
|
| Hydrogels | 1 | 2017 | 102 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2018 | 1223 | 0.140 |
Why?
|
| Biocompatible Materials | 1 | 2017 | 212 | 0.140 |
Why?
|
| Ganglioglioma | 1 | 2015 | 6 | 0.140 |
Why?
|
| Male | 12 | 2018 | 18050 | 0.140 |
Why?
|
| Models, Biological | 2 | 2008 | 377 | 0.130 |
Why?
|
| Epidermal Cyst | 1 | 2013 | 4 | 0.120 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2013 | 10 | 0.120 |
Why?
|
| Cyclin D1 | 1 | 2013 | 27 | 0.120 |
Why?
|
| Aged, 80 and over | 4 | 2012 | 3731 | 0.120 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2013 | 25 | 0.120 |
Why?
|
| Lung Neoplasms | 2 | 2008 | 379 | 0.110 |
Why?
|
| Nitrogen Mustard Compounds | 1 | 2012 | 4 | 0.110 |
Why?
|
| Transcription Factors | 1 | 2013 | 194 | 0.110 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2012 | 31 | 0.110 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2012 | 40 | 0.110 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2012 | 32 | 0.110 |
Why?
|
| Disease Progression | 2 | 2018 | 594 | 0.110 |
Why?
|
| Diagnosis, Differential | 2 | 2010 | 518 | 0.100 |
Why?
|
| Prognosis | 3 | 2018 | 1447 | 0.100 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 686 | 0.100 |
Why?
|
| Medulloblastoma | 1 | 2010 | 7 | 0.100 |
Why?
|
| Cerebellar Neoplasms | 1 | 2010 | 11 | 0.100 |
Why?
|
| Ploidies | 1 | 2010 | 7 | 0.100 |
Why?
|
| Ependymoma | 1 | 2010 | 5 | 0.100 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 42 | 0.100 |
Why?
|
| Radiotherapy | 1 | 2010 | 78 | 0.100 |
Why?
|
| Frontal Lobe | 1 | 2010 | 45 | 0.100 |
Why?
|
| Esophagitis | 1 | 2009 | 5 | 0.100 |
Why?
|
| DNA, Neoplasm | 1 | 2010 | 69 | 0.100 |
Why?
|
| Radial Neuropathy | 1 | 2009 | 10 | 0.090 |
Why?
|
| CA2 Region, Hippocampal | 1 | 2009 | 1 | 0.090 |
Why?
|
| Collagen Type IV | 1 | 2009 | 8 | 0.090 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2009 | 16 | 0.090 |
Why?
|
| Sclerosis | 1 | 2009 | 13 | 0.090 |
Why?
|
| Eosinophilia | 1 | 2009 | 16 | 0.090 |
Why?
|
| Radial Nerve | 1 | 2009 | 17 | 0.090 |
Why?
|
| Alkaline Phosphatase | 1 | 2009 | 36 | 0.090 |
Why?
|
| Crohn Disease | 1 | 2009 | 25 | 0.090 |
Why?
|
| Migraine Disorders | 1 | 2010 | 58 | 0.090 |
Why?
|
| Cell Death | 1 | 2009 | 70 | 0.090 |
Why?
|
| Intestines | 1 | 2009 | 51 | 0.090 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2009 | 5 | 0.090 |
Why?
|
| Image Enhancement | 1 | 2009 | 70 | 0.090 |
Why?
|
| Neural Conduction | 1 | 2009 | 77 | 0.090 |
Why?
|
| Spinal Nerves | 1 | 2009 | 65 | 0.090 |
Why?
|
| Radiosurgery | 1 | 2012 | 317 | 0.090 |
Why?
|
| Hemangioma, Capillary | 1 | 2008 | 3 | 0.080 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2008 | 8 | 0.080 |
Why?
|
| Aneuploidy | 1 | 2008 | 8 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2008 | 10 | 0.080 |
Why?
|
| Monosomy | 1 | 2008 | 5 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2008 | 16 | 0.080 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2008 | 58 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2010 | 429 | 0.080 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 213 | 0.080 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2005 | 2 | 0.070 |
Why?
|
| Neurofibrillary Tangles | 1 | 2005 | 7 | 0.070 |
Why?
|
| tau Proteins | 1 | 2005 | 38 | 0.070 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2005 | 20 | 0.070 |
Why?
|
| Apolipoproteins E | 1 | 2005 | 101 | 0.070 |
Why?
|
| Animals | 4 | 2017 | 7435 | 0.070 |
Why?
|
| Base Sequence | 1 | 2005 | 251 | 0.070 |
Why?
|
| Child | 3 | 2017 | 2174 | 0.060 |
Why?
|
| Feedback, Physiological | 1 | 2004 | 10 | 0.060 |
Why?
|
| Age Factors | 1 | 2008 | 1105 | 0.060 |
Why?
|
| Disease-Free Survival | 2 | 2017 | 307 | 0.060 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2004 | 2 | 0.060 |
Why?
|
| Keratin-20 | 1 | 2004 | 6 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2005 | 297 | 0.060 |
Why?
|
| Intermediate Filament Proteins | 1 | 2004 | 9 | 0.060 |
Why?
|
| Culture Media, Conditioned | 1 | 2004 | 52 | 0.060 |
Why?
|
| Calcium Channel Blockers | 1 | 2004 | 50 | 0.060 |
Why?
|
| Ligands | 1 | 2004 | 82 | 0.060 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2004 | 15 | 0.060 |
Why?
|
| Coculture Techniques | 1 | 2004 | 73 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2005 | 461 | 0.060 |
Why?
|
| Lipopolysaccharides | 1 | 2004 | 109 | 0.060 |
Why?
|
| Presynaptic Terminals | 1 | 2004 | 36 | 0.060 |
Why?
|
| Lymphatic Metastasis | 1 | 2004 | 158 | 0.060 |
Why?
|
| Mice | 2 | 2013 | 2397 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2004 | 275 | 0.060 |
Why?
|
| Genotype | 1 | 2005 | 826 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2004 | 204 | 0.060 |
Why?
|
| Mutation | 2 | 2017 | 516 | 0.060 |
Why?
|
| Aging | 1 | 2009 | 874 | 0.060 |
Why?
|
| Adolescent | 2 | 2017 | 3242 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 646 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2004 | 545 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2004 | 808 | 0.050 |
Why?
|
| Macrophages | 1 | 2002 | 191 | 0.050 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2018 | 12 | 0.040 |
Why?
|
| Sulfones | 1 | 2018 | 14 | 0.040 |
Why?
|
| Indans | 1 | 2018 | 24 | 0.040 |
Why?
|
| RNA Interference | 1 | 2018 | 77 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 110 | 0.040 |
Why?
|
| Electroencephalography | 1 | 2018 | 69 | 0.040 |
Why?
|
| DNA Repair | 1 | 2017 | 49 | 0.040 |
Why?
|
| Injections | 1 | 2017 | 62 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2017 | 3117 | 0.040 |
Why?
|
| Rabbits | 1 | 2017 | 185 | 0.040 |
Why?
|
| Salvage Therapy | 1 | 2015 | 117 | 0.030 |
Why?
|
| Infant | 1 | 2017 | 948 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2010 | 890 | 0.030 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2013 | 3 | 0.030 |
Why?
|
| G2 Phase | 1 | 2013 | 14 | 0.030 |
Why?
|
| Mitosis | 1 | 2013 | 22 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2017 | 1170 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2013 | 21 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 467 | 0.030 |
Why?
|
| Thoracic Vertebrae | 1 | 2013 | 42 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 535 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2013 | 3111 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 1017 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2013 | 106 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 247 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 223 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 199 | 0.030 |
Why?
|
| Radiometry | 1 | 2012 | 39 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 277 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2012 | 165 | 0.030 |
Why?
|
| Apoptosis | 1 | 2013 | 359 | 0.030 |
Why?
|
| Craniopharyngioma | 1 | 2010 | 8 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2010 | 37 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2010 | 36 | 0.020 |
Why?
|
| Pituitary Neoplasms | 1 | 2010 | 17 | 0.020 |
Why?
|
| Proton Pump Inhibitors | 1 | 2009 | 10 | 0.020 |
Why?
|
| Glomerulonephritis | 1 | 2009 | 23 | 0.020 |
Why?
|
| Vasculitis | 1 | 2009 | 25 | 0.020 |
Why?
|
| Deglutition Disorders | 1 | 2009 | 49 | 0.020 |
Why?
|
| Sarcoidosis | 1 | 2009 | 29 | 0.020 |
Why?
|
| Pneumonectomy | 1 | 2008 | 6 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2008 | 19 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2008 | 21 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 88 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2009 | 352 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2008 | 581 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 870 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 2130 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2008 | 1308 | 0.010 |
Why?
|